AU2001292185A1 - Formulation containing amoxicillin - Google Patents

Formulation containing amoxicillin

Info

Publication number
AU2001292185A1
AU2001292185A1 AU2001292185A AU9218501A AU2001292185A1 AU 2001292185 A1 AU2001292185 A1 AU 2001292185A1 AU 2001292185 A AU2001292185 A AU 2001292185A AU 9218501 A AU9218501 A AU 9218501A AU 2001292185 A1 AU2001292185 A1 AU 2001292185A1
Authority
AU
Australia
Prior art keywords
formulation containing
containing amoxicillin
amoxicillin
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292185A
Inventor
Creighton Conley
John Roush
Kevin Storm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Pharmaceuticals Pte Ltd
Original Assignee
Beecham Pharmaceuticals Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Pharmaceuticals Pte Ltd filed Critical Beecham Pharmaceuticals Pte Ltd
Publication of AU2001292185A1 publication Critical patent/AU2001292185A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
AU2001292185A 2000-10-12 2001-10-08 Formulation containing amoxicillin Abandoned AU2001292185A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23978100P 2000-10-12 2000-10-12
US60/239,781 2000-10-12
PCT/IB2001/001899 WO2002030392A2 (en) 2000-10-12 2001-10-08 Formulation containing amoxicillin

Publications (1)

Publication Number Publication Date
AU2001292185A1 true AU2001292185A1 (en) 2002-04-22

Family

ID=22903709

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292185A Abandoned AU2001292185A1 (en) 2000-10-12 2001-10-08 Formulation containing amoxicillin

Country Status (4)

Country Link
US (2) US7011849B2 (en)
EP (1) EP1330236A2 (en)
AU (1) AU2001292185A1 (en)
WO (1) WO2002030392A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US20040219186A1 (en) * 2001-08-16 2004-11-04 Ayres James W. Expandable gastric retention device
GB0130729D0 (en) * 2001-12-21 2002-02-06 Marconi Comm Ltd Communication network
US20060121106A1 (en) * 2003-02-21 2006-06-08 Janez Kerc Therapeutic system comprising amoxicillin and clavulanic acid
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US7838031B2 (en) 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
WO2005112897A2 (en) * 2004-05-21 2005-12-01 Accu-Break Technologies, Inc. Immediate release pharmaceutical tablets with height greater than width
US7780985B2 (en) * 2005-07-12 2010-08-24 Accu-Break Technologies, Inc. Tablets having a printed separation mark to guide breaking
US7329418B2 (en) * 2004-05-21 2008-02-12 Accu Break Technologies, Inc. Pharmaceutical tablets having height greater than width
US7622137B2 (en) * 2004-05-21 2009-11-24 Accu-Break Technologies, Inc. Dosage forms contained within a capsule or sachet
US7713547B2 (en) 2004-05-21 2010-05-11 Accu-Break Pharmaceuticals, Inc. Method of administering a partial dose of a segmented pharmaceutical tablet
US7318935B2 (en) * 2004-05-21 2008-01-15 Accu-Break Technologies, Inc. Pharmaceutical tablets with active and inactive segments
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
KR100714616B1 (en) * 2005-06-23 2007-05-07 삼성전기주식회사 Exponential function generator and variable gain amplifier using the same
AU2005338350A1 (en) * 2005-11-18 2007-05-24 Solapharm, Inc. Segmented pharmaceutical dosage forms
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
US20090111788A1 (en) * 2006-03-24 2009-04-30 Rajesh Jain Antibiotic compositions of modified release and process of production thereof
US20070237815A1 (en) * 2006-04-06 2007-10-11 Lawrence Solomon Dosage forms and methods comprising amlodipine and chlorthalidone
CA2682323A1 (en) 2007-04-02 2008-10-09 Parkinson's Institute Methods and compositions for reduction of side effects of therapeutic treatments
US20130034632A1 (en) * 2011-08-02 2013-02-07 John Cuomo Nutritional supplements containing lipoic acids and sulfur containing compounds
US20130045273A1 (en) * 2011-08-19 2013-02-21 John Cuomo Methods for using nutritional supplements containing lipoic acids and sulfur containing compounds
WO2013173808A2 (en) * 2012-05-17 2013-11-21 Michael Spector Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use
WO2013173803A2 (en) * 2012-05-17 2013-11-21 Michael Spector Formulations of amoxicillin and clavulanate potassium and methods for using same
JP2018511355A (en) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． Drug delivery method and system
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
JP7420797B2 (en) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド Drug delivery methods and systems

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
US4110165A (en) 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
NZ177159A (en) 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
GB1576731A (en) 1976-08-10 1980-10-15 Beecham Group Ltd Process for the preparation of sodium amoxycillin
JO984B1 (en) 1977-10-11 1979-12-01 بيتشام غروب ليمتد K-clavulanate/tri hydrate formulations
IL58461A0 (en) 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
FR2470599A1 (en) 1979-12-07 1981-06-12 Panoz Donald IMPROVEMENTS IN PROCESSES FOR THE PREPARATION OF GALENIC SHAPES WITH DELAYED ACTION AND PROGRAMMED RELEASE AND GALENIC FORMS OF MEDICAMENTS THUS OBTAINED
NZ198241A (en) 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP0080862B1 (en) 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
DE3474023D1 (en) 1983-06-10 1988-10-20 Beecham Group Plc Crystalline amoxycillin salt
US4673637A (en) 1984-04-23 1987-06-16 Hyman Edward S Method for detecting bacteria in urine and for treating rheumatoid arthritis, essential hypertension and other diseases associated with bacteriuria
DE3584522D1 (en) 1984-12-14 1991-11-28 Gergely Gerhard PARTICLES FROM A HYDROPHOBIC OR HARDLY SOLUBLE SUBSTANCE AND METHOD FOR THEIR HYDROPHILIZATION.
JPS61210025A (en) 1985-03-14 1986-09-18 Teisan Seiyaku Kk Stabilized antibioitc complex granule preparation
GB8601204D0 (en) 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
EP0281200B1 (en) 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
US5114929A (en) 1989-03-21 1992-05-19 Beecham Group P.L.C. Pharmaceutical formulation
GB8909793D0 (en) 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
KR910009271B1 (en) 1989-06-20 1991-11-08 김영설 1,1-dioxopenicillanoyl oxymethyl d-6-(alpha-cmethyleneamino phenylacetamide)-penicillanate and p-tolluenesulfonic acid salts
US5814337A (en) 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9007945D0 (en) 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
US5670170A (en) * 1990-04-27 1997-09-23 Beecham Group P.L.C. Pharamaceutical formulation
US5077790A (en) 1990-08-03 1991-12-31 Motorola, Inc. Secure over-the-air registration of cordless telephones
GB9109862D0 (en) 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5861172A (en) 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9114950D0 (en) 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
FI93924C (en) 1991-09-17 1995-06-26 Martti Lauri Antero Marvola A method of preparing a controlled release formulation
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5582837A (en) 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
IT1255522B (en) 1992-09-24 1995-11-09 Ubaldo Conte COMPRESSED FOR THERAPEUTIC USE SUITABLE FOR SELLING ONE OR MORE ACTIVE SUBSTANCES WITH DIFFERENT SPEEDS
DE69425131T2 (en) 1993-01-22 2001-03-15 Smithkline Beecham Plc USE OF CLAVULIC ACID AND AN ANTIBIOTIC FOR TREATING INFECTIONS
GB9311030D0 (en) 1993-05-28 1993-07-14 Smithkline Beecham Corp Pharmaceutical formulations
IL109770A0 (en) 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
US5690959A (en) 1993-05-29 1997-11-25 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
IT1264517B1 (en) 1993-05-31 1996-09-24 Ekita Investments Nv PHARMACEUTICAL TABLET SUITABLE FOR THE RELEASE IN SUBSEQUENT TIMES OF THE ACTIVE PRINCIPLES CARRIED THEREIN
IT1264696B1 (en) 1993-07-09 1996-10-04 Applied Pharma Res PHARMACEUTICAL FORMS INTENDED FOR ORAL ADMINISTRATION ABLE TO RELEASE ACTIVE SUBSTANCES AT A CONTROLLED AND DIFFERENTIATED SPEED
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5500227A (en) 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
US6210714B1 (en) 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
GB9402203D0 (en) 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9405856D0 (en) 1994-03-24 1994-05-11 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
ITMI941169A1 (en) 1994-06-06 1995-12-06 Smithkline Beecham Farma PHARMACEUTICAL FORMULATIONS
US5567439A (en) 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
GB9416599D0 (en) 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
GB9416600D0 (en) 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ1926A1 (en) 1994-09-03 2002-02-17 Smithkline Beckman P L C Pharmaceutical formulations.
IL139728A (en) 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
DZ2028A1 (en) 1995-05-03 2002-10-23 Smithkline Beecham Plc Medicines used to treat bacterial infections in pediatrics.
EP1147771A1 (en) 1995-09-07 2001-10-24 Smithkline Beecham Corporation Pharmaceutical formulation containing amoxycillin and clavulanate
IT1282576B1 (en) 1996-02-06 1998-03-31 Jagotec Ag PHARMACEUTICAL TABLET SUITABLE TO GIVE THE ACTIVE SUBSTANCE IN SUBSEQUENT AND PREDETERMINABLE TIMES
US5773031A (en) 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
GB9617780D0 (en) 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
US5972389A (en) 1996-09-19 1999-10-26 Depomed, Inc. Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
IL119627A (en) * 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
IL131201A (en) 1997-02-14 2005-06-19 Smithkline Beecham Lab Pharmaceutical formulations comprising amoxycillin and clavulanate
SE9700885D0 (en) 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
AU740841B2 (en) 1997-03-25 2001-11-15 Takeda Chemical Industries Ltd. Gastrointestinal mucosa-adherent pharmaceutical composition
JP4083818B2 (en) 1997-06-06 2008-04-30 ディポメド，インコーポレイティド Gastric retentive oral drug dosage form for controlled release of highly soluble drugs
AU1337999A (en) 1997-11-17 1999-06-07 Gist-Brocades B.V. Granules comprising clavulanate and one or more excipients
FR2772615B1 (en) 1997-12-23 2002-06-14 Lipha MULTILAYER TABLET FOR INSTANT RELEASE THEN PROLONGED ACTIVE SUBSTANCES
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
DK200000133U3 (en) * 1999-04-13 2000-07-28 Beecham Pharm Pte Ltd New pharmaceutical formulation
US20020006433A1 (en) 1999-04-29 2002-01-17 Nigel P. Davidson Pharmaceutical formulations
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
WO2001062195A1 (en) 2000-02-24 2001-08-30 Advancis Pharmaceutical Corporation Antibiotic and antifungal compositions
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6375982B1 (en) 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
WO2002030392A2 (en) 2002-04-18
US20020128251A1 (en) 2002-09-12
US20040121013A1 (en) 2004-06-24
EP1330236A2 (en) 2003-07-30
US7011849B2 (en) 2006-03-14
WO2002030392A3 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
AU2001292185A1 (en) Formulation containing amoxicillin
AU2001295657A1 (en) Formulation containing wax-esters
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2002321879A1 (en) Pharmaceutical formulation containing dye
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2001238285A1 (en) Nutritional formulation containing prebiotic substances
AU2002217464A1 (en) Medicinal compositions containing aspirin
AU2002257582A1 (en) Pharmaceutical formulation
AU2001263839A1 (en) Liquid formulations
AU2001262691A1 (en) Cosmetic preparation
AU2001259693A1 (en) Oral devices
AU4328800A (en) Pharmaceutical formulation
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2001248833A1 (en) Stable liquid preparation
AU2001286400A1 (en) Fiber formulation
AU2001283344A1 (en) Dermatological formulation
AU2001296622A1 (en) Oral devices
AU2001273919A1 (en) Pharmaceutical compositions
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU4085201A (en) Pharmaceutical composition
AU5378599A (en) Oral formulation
AU4432001A (en) Trityl-type compounds and their use